Publications
SELECTED
PUBLICATIONS
2023
1. Lee, M. H., Wu, P. F., Chen, T. I. et al. (2023). Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irrespective of coinfection status. JHEP Reports, 5(3), 100634.
2. Chen, Y. J., Hu, K. F., Chan, C. et al. (2023). Association of periodontal disease with migraine: A large‐scale community‐based cross‐sectional study. Headache.
2022
1. Huang, Y. H., Chan, C., Lee, H. W. et al. (2023). Influence of nonalcoholic fatty liver disease with increased liver enzyme levels on the risk of cirrhosis and hepatocellular carcinoma. Clinical Gastroenterology and Hepatology, 21(4), 960-969.
2021
1. Liao, S. F., Koshiol, J., Huang, Y. H. et al. (2021). Postdiagnosis aspirin use associated with decreased biliary tract cancer–specific mortality in a large nationwide cohort. Hepatology, 74(4), 1994-2006.
2020
1. Lee, M. H., Huang, Y. H., Coghill, A. E. et al. (2021). Epstein-Barr virus-based nasopharyngeal carcinoma (NPC) risk prediction scores are elevated in NPC multiplex family members in Taiwan. The Journal of Infectious Diseases, 223(3), 441-444.
2. Lee, M. H., Gao, Y. T., Huang, Y. H. et al. (2020). A metallomic approach to assess associations of serum metal levels with gallstones and gallbladder cancer. Hepatology, 71(3), 917-928.
3. Huang, Y. H., Khor, S. S., Zheng, X. et al.(2020). A high-resolution HLA imputation system for the Taiwanese population: a study of the Taiwan Biobank. The Pharmacogenomics Journal, 20(5), 695-704.
4. Huang, C., Chen, S. P., Huang, Y. H. et al. (2020). HLA class I alleles are associated with clinic-based migraine and increased risks of chronic migraine and medication overuse. Cephalalgia, 40(5), 493-502.
5. Huang, Y. H., Liao, S. F., Khor, S. S. et al. (2020). Large‐scale genome‐wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Alimentary Pharmacology & Therapeutics, 52(4), 682-691.
2018
1. Lee, M. H., Huang, Y. H., Chen, H. Y. et al. (2018). Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: a genome‐wide association study. Hepatology, 67(2), 651-661.
